On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Pregnancy: More than 3 Increases Atherosclerosis Risk
Women who have 4 or more children have a higher risk of developing atherosclerosis, a Texas study found. Researchers who analyzed data on coronary artery calcium and aortic wall thickness found these 2 cardiac risk factors were most pronounced in that high-birth group and far lower in women who had 2 or 3 children. Curiously, women who had 1 or no children also showed they had the risk factors similar to the high-birth group.
Managing Comorbid Type 2 Diabetes Mellitus and HIV
March 24th 2015Approximately 14% of patients infected with human immunodeficiency virus (HIV) also have type 2 diabetes mellitus. That number is expected to rise as the population of HIV-infected patients ages and develop associated chronic comorbidities.
We Want a Boy: The Ethics of Sex Selection in the Clinic
March 24th 2015Controversy is no rarity in the field of reproductive endocrinology and infertility. Since its discovery and early clinical applications, everyone seemed to have (and still has) an opinion about in vitro fertilization (IVF) procedures.
Exocrine Pancreatic Function Measured with Ultrasonography and Endoscopic Short Tests
Secretin stimulated ultrasonography can assess pancreatic fluid flow and can combine with endoscopic short tests to evaluate exocrine pancreatic function, according to research published in the Scandinavian Journal of Gastroenterology.
Lung's Immune Response Damaged by E-cigarettes
March 24th 2015E-cigarettes -- thought by many to be a "healthier" alternative to tobacco cigarettes -- were found by John Hopkins Bloomberg School of Public Health investigators to not only compromise the lung's immune system, but to also include some of the same chemicals present in traditional cigarettes.
COPD and Smoking Are Tied to Increased Risk of Osteoporosis, Fractures
March 24th 2015Current osteoporosis guidelines don't recommend screening for men. However, researchers from National Jewish Health have identified men's smoking history and chronic obstructive pulmonary disease (COPD) as risk factors for osteoporosis and fractures of the vertebrae.
Cystic Fibrosis Discovery Provides Insight into Other Pulmonary Conditions
March 24th 2015In patients with cystic fibrosis, the mucus molecular bonds become more complex due to inflammation, creating an "elastic sludge" effect, according to a team of researchers from University of California San Francisco who claimed their findings could also be beneficial for other respiratory conditions such as COPD and asthma.
Study: Short Stays OK after Percutaneous Coronary Intervention
Pressure on US hospitals to cut costs is fueling a new trend, sending patients home as little as 2 days after primary percutaneous coronary intervention after a serious heart attack. Most US patients go home in 4 to 5 days. A new study finds the short stay is usually safe and the research will likely add momentum to the trend.
Stelara Recommended to Treat Psoriatic Arthritis in the United Kingdom
The National Institute for Health and Care Excellence in United Kingdom has recommended Janssen's Stelara for the treatment of psoriatic arthritis, adding to its recommendation of the drug already to treat plaque psoriasis.
Vitamin D Fails Fall-Prevention Test
Falls are a constant health threat for older people. A study in Finland looked at whether vitamin D supplements, exercise, or both could lessen the risk of falling for women ages 70 to 80. The US Preventive Services Task Force recommends that those at risk of falling should take vitamin D. A new study finds that does not help.
Cost Burden of New Hepatitis C Drugs, Effect on Health Care System, Analyzed
March 22nd 2015Researchers who analyzed the cost of new high-price hepatitis C drugs found them to be cost effective for most patients yet likely to weigh down budgets of US government and insurance providers for years to come like no drug ever before.